<i>Strong</i>-LAMP Assay Based on a <i>Strongyloides</i> spp.-Derived Partial Sequence in the 18S rRNA as Potential Biomarker for Strongyloidiasis Diagnosis in Human Urine Samples

<div>TD-PCR analysis of patients’ urine samples. (a) PCR for verifying F3 and B3 primer functioning for amplifying the 214 bp fragment. (b) Samples from the Hospital de Poniente (El Ejido, Almería). (c) Samples from the Hospital Clínic de Barcelona. M: molecular weight marker (DNA Ladder 100 bp PLUS BLUE); C+: <i>Strongyloides venezuelensis</i> DNA (positive control); C−: ultrapure water, no DNA (negative control).</div>

Disease Markers

fig1

Figure 1

Figure 1: <i>Strong</i>-LAMP Assay Based on a <i>Strongyloides</i> spp.-Derived Partial Sequence in the 18S rRNA as Potential Biomarker for Strongyloidiasis Diagnosis in Human Urine Samples 

Figure 1 | Strong-LAMP Assay Based on a Strongyloides spp.-Derived Partial Sequence in the 18S rRNA as Potential Biomarker for Strongyloidiasis Diagnosis in Human Urine Samples 